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Abstract 
In order to understand the relationship between peroxisomal dysfunction and clinical manifestations of peroxisomal disorders, the 
effect of thioridazine, a peroxisomal/3-oxidation antagonist, on the differentiation, membrane lipid composition and membrane fluidity of 
C-6 glial cells was examined. In our study, induction of 2',3'-cyclic-nucleotide 3'-phosphohydrolase (CNP), which was considered to be a 
membrane-associated enzyme closely associated with myelination, was inhibited with supplementation f thioridazine, followed by an 
increase in the relative concentration of longer chain fatty acids in cell membrane lipids, indicating that thioridazine causes impaired 
differentiation i the glial stem cell system. Membrane fluidity of C-6 glial cells was examined using a fluorescent probe 1,6-diphenyl- 
1,3,5-hexatriene (DPH). The DPH anisotropy value was decreased in the glial cells treated with thioridazine. These results indicate that 
the alteration of the membrane lipid composition caused by thioridazine affects the differentiation of glial cells via the changes in 
membrane properties. 
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1. Introduction 
In patients with peroxisomal disorders such as Zell- 
weger syndrome, severe neurological abnormalities are 
present [1-3]. Such patients show a number of metabolic 
abnormalities including an accumulation of very long chain 
fatty acids and pipecolic acid in the tissue and the body 
fluid [4,5], and a decreased level of plasmalogen i  tissues 
[6]. Pathological cytoarchitectonic abnormalities resulting 
from migration arrest have been described in developmen- 
tal neuronal tissues [7-9]. However, the role of the 
metabolic abnormalities in the dysfunction of the nervous 
system in peroxisomal disease remains unknown. 
Abbreviations: CNP, 2',3'-cyclic-nucleotide 3'-phosphohydrolase; 
DMEM, Dulbecco's modified Eagle's medium; DPH, 1,6-diphenyl- 
1,3,5-hexatriene. 
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One of the cell culture models of the developing brain, 
C-6 glial cells are considered to have properties of glial 
stem cells [10]. They have oligodendroglia-like properties 
when they are cultured in serum-free medium or at high 
density. Induction of 2',3'-cyclic-nucleotide 3'-phos- 
phohydrolase (CNP), a marker enzyme of myelin and 
oligodendroglia, occurs upon transfer of C-6 glial cells to a 
serum-free medium [11-14]. It was reported that thiorida- 
zine, one of the phenothiazine derivatives, inhibits peroxi- 
somal /3-oxidation in hepatocytes [15,16]. Since the inhibi- 
tion of /3-oxidation is the major abnormality in peroxiso- 
mal disorders, investigating the effect of thioridazine on 
developing neural cells could be an aid to understand the 
mechanism of neurological manifestations. 
The effect of thioridazine on CNP activity was exam- 
ined in this study using cultured C-6 glial cells. In addi- 
tion, the changes in the nature of C-6 cell membrane such 
as fatty acid composition and membrane fluidity upon 
culture with thioridazine were studied. 
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2. Materials and methods 
2.1. Cell culture 
C-6 glial cells were obtained from the American Type 
Culture Collection (Rockville, MD) and routinely cultured 
with Dulbecco's modified Eagle's medium (DMEM) sup- 
plemented with 10% fetal calf serum. The stock of C-6 
glial cells were cultured for 3 days and washed with 
phosphate buffer. To induce the differentiation of C-6 glial 
cells, they were cultured for additional 2 days in serum-free 
medium with 0 to 0.04 mM thioridazine. They were 
harvested mechanically and the cell pellets were frozen in 
liquid N 2 until the enzyme assay was performed. 
2.2. CNP activity 
CNP activity was measured by the previously reported 
method [10]. Essentially, C-6 glial cells were homogenized 
and solubilized with sodium deoxycholate. The solution 
was added to 2',3'-cyclic-monophosphate, and the amount 
of inorganic phosphorus released from adenosine 2',3'- 
cyclic-monophosphate was determined by the methods of 
Ames [17]. Protein assay was done by the method of 
Lowry et al. [18]. 
2.3. Lipids extraction and fatty acid analysis 
Fatty acid analysis was done by the method of MacGee 
and Allen [19]. Fatty acids were extracted with n-hexane 
after saponification of total lipids from the homogenized 
cells and were neutralized. Then trimethyl-a,a,a-triflu- 
oro-m-tolyl ammonium hydroxide was added to take up 
free fatty acids from the hexane phase, followed by their 
methylation on the capillary column (Omegawax 320 0.32 
mm, 30 m, Supeluco) of a gas chromatograph (GC-14A, 
Shimadzu). The initial temperature was 150°C and the 
temperature was raised 10 ° C per min to the final tempera- 
ture of 270 ° C. The peak area was calculated with Chro- 
matopack (C-R5A, Shimadzu). 
2.4. Determination of total cellular cholesterol and phos- 
pholipid 
Cells were suspended in 0.9% (w/v)  NaC1 solution and 
lipids were extracted with NaC1 solution/methanol/chlo- 
roform (3:4:8 by volume). An aliquot of the chloroform 
layer was used for quantitation of total cellular cholesterol 
and lipid-bound phosphorus. Total cholesterol was mea- 
sured by the colorimetric assay with cholesterol oxidase 
(Boehringer-Mannheim). Total lipid-bound phosphorus was 
measured by the method of Ames [17]. 
2.5. Membrane fluidity 
Membrane fluidity was monitored according to the 
method of Kawato et al. [20] In brief, a lipophilic probe, 
1,6-diphenyl-l,3,5-hexatriene (DPH) was added to the ho- 
mogenized C-6 glial cells and embedded in the membrane 
by incubation at 37°C for 20 rain. Fluorescence intensity 
was measured with a fluorescence spectrophotometer (FP- 
2070, JASCO). The excitation wavelength was 360 nm, 
and the emission light (426 nm) was polarized vertically 
( I  v) and horizontally (Ih) by a polarizing filter. The 
steady-state mission anisotropy (r)  was calculated as 
follows. 
r 
Iv + 2Ih 
All chemicals and solvents were of reagent grade. 
Thioridazine was obtained from Sandoz Yakuhin (Tokyo). 
3. Results 
3.1. CNP activity 
The effect of thioridazine on CNP activity is shown in 
Table 1. The activity of CNP decreased as a function of 
thioridazine concentration. The induction of CNP activity 
at the concentration of 0.04 mM thioridazine was sup- 
Table 1 
Effect of thioridazine on CNPase activity in C-6 glial cells 
Medium CNP (nmol/min per mg protein) Protein (rag/flask) 
DMEM with 10% FCS 149 5:11 1.9 + 0.1 
Serum-free DMEM 408 5:26 1.9 + 0.1 
Serum-free DMEM 
+0.01 mM thioridazine 375 + 11 2.1 + 0.2 
+ 0.02 mM thioridazine 321 5:30 1.9 + 0.2 
+0.04 mM thioridazine 214 5:11 2.0 + 0.3 
C-6 glial cells were cultured inDMEM medium with 10% fetal calf serum for 3 days. Then glial cell differentiation was induced by culture for 2 days in 
serum-free medium. Results of CNPase activity and protein assay are the means for three determinations. 
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Table 2 
Fatty acid composition i  C-6 glial cells cultured in serum-free medium with or without hioridazine 
% of total fatty acids 
serum-free medium serum-free medium with thioridazine 
C14:0 2.1 +0.2 4.2 ±0.4 
C16:0 18.6 +1.5 22.1 +1.4 
C16:1 6.8 +0.8 6.1 ±0.4 
C18:0 13.0 ±1.0 14.4 ±1.1 
C18:0 40.4 +2.4 33.0 ±2.5 
C20:0 1.2 +0.1 1.0 +0.1 
C20:4 2.2 ± 0.2 2.9 + 0.2 
C22:0 0.4 +0.1 0.8 ±0.1 
C22:6 1.3 -I-0.4 1.5 ±0.3 
C24:0 1.0 ±0.2 1.4 ±0.1 
Others 13.7 ±2.4 18.6 ±1.5 
A, sum of C14-20 93.7 ±0.6 90.0 +1.1 
B, sum of C22-24 4.23 + 0.3 6.16 ± 0.25 
B/A 0.045 ± 0.004 * 0.068 ± 0.003 * 
c-6 glial cells were cultured in DMEM medium with 10% fetal calf serum for 3 days. To induce glial cell differentiation, cells were transferred to 
serum-free medium. Thioridazine was added to the serum-free medium. Fatty acid compositions in the total lipid extracts were examined by GLC. 
* P ,0 .01 .  
pressed to half  of  the level in cells cultured with serum-free 
medium. The amount of protein in each flask measured 
concomitantly with CNP activity was unchanged, indicat- 
ing that thioridazine does not affect cell proliferation. 
Since CNP is a marker enzyme for ol igodendroglia, this 
result indicates that thioridazine suppresses the differentia- 
tion of  C-6 glial cells. CNP activity was induced in 
serum-free media after transfer of  cells to medium contain- 
ing no thioridazine (data not shown), indicating that the 
effect of  thioridazine on C-6 glial cell differentiation is 
reversible. 
3.2. Fatty acid composition in C-6 glial cell 
The relative concentration of longer chain fatty acids 
was increased by culture of  the cells in the presence of  
0.04 mM thioridazine (Table 2). The ratio of  C22- 
C24/C14-C20,  which was 0.045 + 0.004 in the C-6 glial 
cells cultured in serum-free medium containing no thiori- 
dazine, increased to 0.068 + 0.003 in those subsequently 
cultured in serum-free medium supplemented with thiori- 
dazine. 
3.3. Concentration of total cellular cholesterol and phos- 
pholipids 
Concentrations of  total phospholipids and cholesterol in 
C-6 glial cells are shown in Table 3. Contents of  phospho- 
lipids and cholesterol per mg of protein decreased upon 
transfer to serum-free medium. The concentrations of  both 
cholesterol and phospholipids were increased in the cells 
cultured in the presence of  0.04 mM thioridazine. How-  
Table 3 
Effect of thioridazine on the ratio of phospholipids to cholesterol in C-6 glial cells 
C-6 glial cells PL (nmol/mg protein) Chol (nmol/mg protein) Ratio PL/Chol 
FCS medium 57.1 + 3.8 191 + 2.4 0.30 
FCS-free medium 44.6 + 2.4 142 + 5.7 0.31 
FCS-free medium with thioridazine 72.6 + 4.1 234 + 9.0 0.31 
Phospholipids (PL) and cholesterol (Chol) were quantitated as described in the text. Values are the means of three separate xperiments. 
Table 4 
Fluorescent anisotropy values in the C-6 glial cell membrane treated with DPH 
Fluorescent anisotro.py value 
FCS medium FCS-free medium 
Thioridazine (mM): 0 0 0.01 0.02 0.04 
0.190 + 0.002 0.189 + 0.002 0.174 + 0.001 * 0.169 + 0.005 * * 0.166 + 0.003 * 
2 ml of cell suspension in PBS (0.5 mg protein/ml) was added to 2 /.d of DPH solution (190 mM) in a cuvette and the fluorescent anisotropy was 
measured after incubation at 37 ° C for 20 min. The values denote mean + S.D. from four separate determinations. Values marked with asterisk and double 
asterisk differ from control (FCS medium without hioridazine) with P values of 0.01 and 0.02, respectively. 
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Fig. 1. The effect of 0.04 mM thioridazine added to serum-free medium 
(~) on membrane fluidity of C-6 glial cells as a function of time. 
Membrane fluidity of cells cultured with serum-free medium (O) and 
medium containing 10% fetal calf serum (t~) was also monitored by 
DPH fluorescence anisotropy. Results of anisotropy of each cell are the 
means for three determinations and the error bars represent S.D. 
ever, no difference in the molar ratio of total phospho- 
lipid/cholesterol was observed among the cells cultured in 
serum-supplemented medium, and those cultured in 
serum-free medium with or without hioridazine. 
3.4. Membrane fluidity 
The effect of thioridazine on steady-state anisotropy 
values of DPH-labeled C-6 glial cells was determined after 
treatment of the cells with various concentrations of thiori- 
dazine as shown in Table 4. The anisotropy values for C-6 
glial cells cultured with and without 10% fetal calf serum 
at 37°C were 0.190 __+ 0.002 and 0.189 __+ 0.002, respec- 
tively. When thioridazine was added to the serum-free 
medium, the anisotropy values decreased with increasing 
concentration of thioridazine. The steady-state anisotropy 
value for C-6 glial cells cultured in the presence of 0.04 
mM thioridazine was 0.166 + 0.003, which was a 12% 
reduction from that for the control cells. Thus, although 
the membrane fluidity was not changed upon transfer to 
serum-free medium, the addition of thioridazine to serum- 
free medium resulted in a significant increase of mem- 
brane fluidity compared with those cells cultured in fetal 
calf serum (FCS)-medium containing no thioridazine. The 
effect of thioridazine as a function of time is shown in Fig. 
1. DPH anisotropy significantly decreased 2 days after the 
medium change with added 0.04 mM thioridazine. 
4. Discussion 
Several investigators have studied the possible relation- 
ship between the induction of CNP and lipid components 
of glial cells. Volpe and Obert demonstrated that one of 
the major cellular lipids, cholesterol was critical for mani- 
festation of oligodendroglial differentiation i  C-6 glial 
cells [21]. In a study on another major cellular lipid, 
phospholipid, CNP activity in C-6 glial cells was sup- 
pressed by incorporation of the choline analogue N,N'-di- 
methylethanolamine into cellular membrane [22]. Yavin et 
al., reported that membrane fluidity in cultured neuroblas- 
toma cells increased by incubation of the cells with N,N'- 
dimethylethanolamine [23]. Based on these results, Volpe 
et al., suggested that an increase of membrane fluidity 
resulted in suppression of induction of CNP [22]. In the 
present study, we also demonstrated that the decreased 
CNP activity was closely correlated with the increased 
membrane fluidity and that the change in membrane fluid- 
ity of the cells cultured in the presence of thioridazine was 
due to the accumulation of relatively longer chain fatty 
acids in C-6 glial cells. Although an elevated levels of very 
long chain fatty acids should lower membrane fluidity, the 
increased membrane fluidity in our study might be related 
to the elevation of unsaturated fatty acids (C > 20). The 
effect of thioridazine on membrane fluidity was dependent 
on time of supplementation. I  order to assess the direct 
effect of thioridazine on membrane fluidity measurement 
with DPH, homogenized C-6 glial cells grown in serum- 
free medium were mixed with thioridazine solution just 
before the anisotropy assay. The DPH-labelled anisotropy 
values (data not shown) increased indicating decreased 
membrane fluidity. Therefore, it was suggested that 
changes in membrane fluidity of C-6 glial cells cultured 
with thioridazine was not due to the direct perturbation of 
membrane but the alteration of membrane fatty acid com- 
position via inhibition of peroxisomal function. In accor- 
dance with the results that incubation with thioridazine l d 
to increased synthesis of phospholipids [24], the concentra- 
tion of phospholipids in the cells cultured in serum-free 
medium with thioridazine increased to a level 1.6-times 
higher than that of cells cultured without thioridazine in 
the recent study. Simultaneously, the concentration of 
cholesterol increased in the cells upon culture with thiori- 
dazine, so that there was no difference in the ratios of 
cholesterol to phospholipids between the cells treated with 
or without hioridazine. Zubenko and Cohen examined the 
effect of thioridazine on the physical properties of platelet 
membrane and showed a significant increase in fluorescent 
polarization of DPH [25]. The effect of phenothiazines on
the molecular dynamics of lipid bilayers is complex and 
might depend on the membrane system examined [26,27]. 
Therefore, the effect of phenothiazines on neural cells 
which are rich in lipid might differ from that on platelet 
membrane. In our study, thioridazine, a peroxisomal fl- 
oxidation antagonist, affected C-6 glial cell differentiation, 
presumably through the changes in fatty acid composition 
and membrane fluidity. Although the changes which pre- 
sent in membrane properties are still unclear in peroxiso- 
mal disorders with the multiple metabolic abnormalities, it 
is implicated that cellular dysfunction i  peroxisomal dis- 
orders might be relevant o the altered membrane fluidity 
in neural cells. Further study is necessary to understand the 
role of altered membrane fluidity in vivo. 
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